|Last Price$19.72||Day Change (%)1.54%|
|Open Price$19.33||Day Change ($)0.30|
|Day Range19.33–19.82||52-Week Range9.80–21.65|
As of Thu 04/17/2014 03:44 PM EST | USD
The new General Motors is much leaner than its predecessor, and any near-term litigation risk will have little impact on the automaker's 1.85 billion diluted shares.
Clinigen Group Acquires Oncology Support Therapy SAVENE® (dexrazoxane) from SpePharm AG
Our fair value estimate and moat rating remain intact.
Even after a strong rebound from the market trough in 2009, the U.S. auto sector still has room to run.
Wasatch's Sam Stewart looks for companies that do things so differently that they can change an industry forever.